Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
October 7, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
Close Move
All Press Releases for May 20, 2008 Subscribe to this News Feed      
 

LegalView Updates Mesothelioma Victims on a Push to Increase Federal Funding for Asbestos-Related Illnesses and Deaths

LegalView reported to mesothelioma blog readers that several U.S. senators and lobbyists are supporting a push to increase federal funding for researching asbestos-related illnesses. The 2009 defense appropriations bill is at the epicenter for the cancer research because of the vast array of Navy men who are currently diagnosed with mesothelioma and at risk for the condition.

Denver, CO (PRWEB) May 20, 2008 -- LegalView.com, a definitive source for everything legal on the Internet, recently updated its mesothelioma legal information blog readers on an extensive push by congressmen and lobbyists at the federal level to increase funding for cancer research, specifically mesothelioma cancer. At the center of this move for more mesothelioma research funding is the 2009 defense appropriations bill. The defense appropriations bill, while a seemingly unlikely source for cancer funding, is appropriating funds for asbestos because of the at least one third of mesothelioma sufferers who previously served in the Navy worked at a Navy shipyard.

Mesothelioma is an incurable form of cancer that is caused through the inhalation of asbestos fibers and asbestos dust. Individuals who currently suffer from this deadly form of cancer are advised to explore LegalView's database of mesothelioma attorneys, as treating the symptoms of mesothelioma can be a costly endeavor.

Asbestos is derived from a mineral known as vermiculite, which was mined throughout the 20th century up until it was discovered that even minimal exposure to asbestos dust and fibers could be toxic. Asbestos was, however, widely used as an insulator for homes, apartment buildings, schools, universities, hospitals, government buildings and in shipbuilding. It was prized for its resistance to become flammable and its low costs of production. Currently, the Environmental Protection Agency (EPA) regulates the removal of asbestos from buildings, as it can be easily exposed to individuals if proper cleanup methods are not used. Those who feel they may have been exposed to mesothelioma should consider contacting a mesothelioma lawyer for experienced counsel.

Asbestos was widely used to insulate boilers, incinerators, and steam and hot water pipes aboard ships. Individuals who worked for the Navy were often exposed to asbestos within ships or asbestos during shipbuilding. This was especially true during the height of World War II. Those who feel they may have been exposed to asbestos or those who have been diagnosed with the cancer should speak with a medical professional immediately, as mesothelioma is often dormant for years and even decades, at which point, treatment is nearly impossible. Also, to learn more about developing litigation it is best to locate an experienced mesothelioma attorney who can advise victims on proper courses of action and can help with the consideration of a mesothelioma lawsuit, which may provide much needed monetary compensation.

In addition to the extensive mesothelioma information portal, LegalView offers practice areas on other legal issues including Digitek's digoxin recall, Singulair side effects and the Chantix risks. Digitek is the brand of a heart medication, digoxin. The medication is used to treat heart failure and other irregular heart rate conditions such as atrial fibrillation and atrial flutter. The Digitek recall spawns from a U.S. Food and Drug Administration (FDA) report that the recently manufactured Digitek digoxin tablets may contain twice the approved level of active ingredient, due to a manufacturing defect. The defective pills can cause digitalis toxicity, which can have severe effects among patients including renal failure and death.

Similar to the Digitek recall are the information portals on the Singulair side effects and Chantix risks. Singulair is a medication prescribed to asthma sufferers, but was recently discovered to have increased the risk of suicide and suicidal tendencies among patients. Similarly, Chantix, a smoking-cessation drug, was recalled from the market after reports of depression, erratic behavior and suicide by patients surfaced. Unfortunately, Chantix may have been responsible for at least 38 suicides before being pulled from the shelves. For more information on these topics or to peruse the vast array of other legal issues, visit http://www.LegalView.com/.

About LegalView:
LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com/.

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/SW5zZS1GYWx1LU1hZ24tTG92ZS1DcmFzLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
Katie Kelley
LegalView
720-771-3246
Email us Here
Alan Haburchak
LegalView
720-771-3246
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your login.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright